Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: Results from a German population-based case-control study

Evidence has accumulated which suggests that sex steroids influence colorectal cancer development and progression. We therefore assessed the association of repeat polymorphisms in the estrogen receptor β gene (ESR2) and the androgen receptor gene (AR) with colorectal cancer risk and prognosis.